Thalomid (thalidomide) — Medica
Histiocytic neoplasms (Langerhans cell histiocytosis or Rosai-Dorfman cutaneous disease)
Initial criteria
- age ≥ 18 years
- For Langerhans cell histiocytosis: single-system multifocal skin disease OR relapsed/refractory disease; OR Patient has Rosai-Dorfman cutaneous disease
Approval duration
1 year